Literature DB >> 35138443

The mouse resource at National Resource Center for Mutant Mice.

Cunxiang Ju1, Juan Liang1, Mingkun Zhang1, Jinlong Zhao1, Ling'en Li1, Shuai Chen2,3, Jing Zhao4, Xiang Gao5,6,7.   

Abstract

Mouse models are essential for dissecting disease mechanisms and defining potential drug targets. There are more than 18,500 mouse strains available for research communities in National Resource Center for Mutant Mice (NRCMM) of China, affiliated with Model Animal Research Center of Nanjing University and Gempharmatech Company. In 2019, Gempharmatech launched the Knockout All Project (KOAP) aiming to generate null mutants and gene floxed strains for all protein-coding genes in mouse genome within 5 years. So far, KOAP has generated 8,004 floxed strains and 9,769 KO (knockout) strains (updated to Oct, 2021). NRCMM also created hundreds of Cre transgenic lines, mutant knock-in models, immuno-deficient models, and humanized mouse models. As a member of the international mouse phenotyping consortium (IMPC), NRCMM provides comprehensive phenotyping services for mouse models. In summary, NRCMM will continue to support biomedical community with new mouse models as well as related services.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Humanized mice; Knockout; Mouse resource; Transgenic mice

Mesh:

Year:  2022        PMID: 35138443     DOI: 10.1007/s00335-021-09940-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  75 in total

1.  Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.

Authors:  Xiuqin Bao; Xinhua Zhang; Liren Wang; Zhongju Wang; Jin Huang; Qianqian Zhang; Yuhua Ye; Yongqiong Liu; Diyu Chen; Yangjin Zuo; Qifa Liu; Peng Xu; Binbin Huang; Jianpei Fang; Jinquan Lao; Xiaoqin Feng; Yafeng Li; Ryo Kurita; Yukio Nakamura; Weiwei Yu; Cunxiang Ju; Chunbo Huang; Narla Mohandas; Dali Li; Cunyou Zhao; Xiangmin Xu
Journal:  Am J Hum Genet       Date:  2021-03-17       Impact factor: 11.025

2.  Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.

Authors:  Eva Billerbeck; Walter T Barry; Kathy Mu; Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Blood       Date:  2011-01-20       Impact factor: 22.113

3.  Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.

Authors:  Tadashi Ashizawa; Akira Iizuka; Chizu Nonomura; Ryota Kondou; Chie Maeda; Haruo Miyata; Takashi Sugino; Koichi Mitsuya; Nakamasa Hayashi; Yoko Nakasu; Kouji Maruyama; Ken Yamaguchi; Ikumi Katano; Mamoru Ito; Yasuto Akiyama
Journal:  Clin Cancer Res       Date:  2016-07-25       Impact factor: 12.531

4.  Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Authors:  Michael A Brehm; Amy Cuthbert; Chaoxing Yang; David M Miller; Philip DiIorio; Joseph Laning; Lisa Burzenski; Bruce Gott; Oded Foreman; Anoop Kavirayani; Mary Herlihy; Aldo A Rossini; Leonard D Shultz; Dale L Greiner
Journal:  Clin Immunol       Date:  2010-01-21       Impact factor: 3.969

5.  The knockout mouse project.

Authors:  Christopher P Austin; James F Battey; Allan Bradley; Maja Bucan; Mario Capecchi; Francis S Collins; William F Dove; Geoffrey Duyk; Susan Dymecki; Janan T Eppig; Franziska B Grieder; Nathaniel Heintz; Geoff Hicks; Thomas R Insel; Alexandra Joyner; Beverly H Koller; K C Kent Lloyd; Terry Magnuson; Mark W Moore; Andras Nagy; Jonathan D Pollock; Allen D Roses; Arthur T Sands; Brian Seed; William C Skarnes; Jay Snoddy; Philippe Soriano; David J Stewart; Francis Stewart; Bruce Stillman; Harold Varmus; Lyuba Varticovski; Inder M Verma; Thomas F Vogt; Harald von Melchner; Jan Witkowski; Richard P Woychik; Wolfgang Wurst; George D Yancopoulos; Stephen G Young; Brian Zambrowicz
Journal:  Nat Genet       Date:  2004-09       Impact factor: 38.330

Review 6.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

7.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.

Authors:  T Blunt; N J Finnie; G E Taccioli; G C Smith; J Demengeot; T M Gottlieb; R Mizuta; A J Varghese; F W Alt; P A Jeggo; S P Jackson
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

8.  Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.

Authors:  Lei Bai; Yongliang Zhao; Jiazhen Dong; Simeng Liang; Ming Guo; Xinjin Liu; Xin Wang; Zhixiang Huang; Xiaoyi Sun; Zhen Zhang; Lianghui Dong; Qianyun Liu; Yucheng Zheng; Danping Niu; Min Xiang; Kun Song; Jiajie Ye; Wenchao Zheng; Zhidong Tang; Mingliang Tang; Yu Zhou; Chao Shen; Ming Dai; Li Zhou; Yu Chen; Huan Yan; Ke Lan; Ke Xu
Journal:  Cell Res       Date:  2021-02-18       Impact factor: 25.617

9.  Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.

Authors:  Michael A Brehm; Laurie L Kenney; Michael V Wiles; Benjamin E Low; Roland M Tisch; Lisa Burzenski; Christian Mueller; Dale L Greiner; Leonard D Shultz
Journal:  FASEB J       Date:  2018-11-01       Impact factor: 5.834

Review 10.  Advances in mouse genetics for the study of human disease.

Authors:  Steve D M Brown
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.